Maimonides is offering COVID-19 vaccine appointments to those who are eligible per city, state, and federal guidelines. Please do not call or email to request an appointment. We are notifying eligible individuals as supplies become available.

Clinical Trials

Showing 21-26 of 26 Results

PERIGON

This is a multi-center, non-randomized trial to determine the safety and effectiveness of the Model 400 aortic valve bioprosthesis in patients with aortic valve disease.

PARADISE-MI (LCZ696G2301)

This is a multi-center, randomized, double-blind, active-controlled, parallel-group Phase 3 study to evaluate the efficacy and safety of LCZ696 compared to ramipril on morbidity and mortality in high risk patients following and acute myocardial infarction.

OPTISURE

This purpose of this post approval study is to characterize the chronic performance of the SJM Optisure family of HV leads in patients that have an approved indication, as per ACC/AHA/HRS/ESC guidelines, for implantation of an ICD or CRT-D system for treatment of heart failure or life-threatening ventricular tachyarrhythmia, and…

Navigate X4

Evaluation of ACUITY™ X4 Quadripolar Coronary Venous Leads and RELIANCE™ 4-FRONT Defibrillation Leads.

HeartMate PHP™ (SHIELD)

The purpose of this study is to assess the safety and efficacy of the HeartMate PHP™ in supporting patients with severe symptomatic coronary artery disease with diminished but stable cardiovascular function, who are undergoing elective or urgent high risk percutaneous coronary interventions (PCI) but are not candidates for coronary artery…

CONVERGE

Convergence of Epicardial and Endocardial Radiofrequency Ablation for the treatment of symptomatic persistent Atrial Fibrillation.

Showing 21-26 of 26 Results